The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.Additionally, a review of the complaint history identified no lot specific product issue.The reported patient effects of dyspnea, weakness and mitral regurgitation as listed in the mitraclip system instructions for use, are known possible complication associated with mitraclip procedures.All available information was investigated and a definitive cause for the reported single leaflet device attachment/slda could not be determined.The recurrent mitral regurgitation/mr was due to the slda.Moreover, weakness and dyspnea were reportedly present prior to procedure and are due to challenging patient morphology/pathology.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
This is filed to report the single leaflet device attachment (slda).It was reported the mitraclip procedure was performed on (b)(6) 2020 to treat functional mitral regurgitation (mr) with a grade of 4.There were some difficulties with visualization, due to the patient anatomy one clip was implanted, reducing mr to 1.Two days following the procedure ((b)(6) 2020), while the patient was still at the hospital, the patient experienced dyspnea and reduced exercise capacity, similar symptoms he had prior to the procedure.Echocardiogram was performed, the clip had detached from the short posterior leaflet and remained attached to the anterior leaflet (slda).Mr increased to 4.The patient remained hospitalized with intravenous diuretics and was discharged on day five with some improvement.There was conversation with the family about the possibility of implantation of a second clip at a later date.No additional information was provided.
|